SPECT/CT imaging of apoptosis in aortic aneurysm with radiolabeled duramycin

The objective of this research was to estimate whether a[99mTc]duramycin probe can be used for apoptosis imaging in patients with aortic aneurysm (AA). Vascular smooth muscle cell (SMC) apoptosis has an important influence on AA development. Thus, non-invasive imaging of SMC apoptosis may be able to evaluate AA progress and risk stratification. SMCs were treated with hydrogen peroxide (H2O2; 200  μΜ) or culture medium as a control. Apoptosis was measured using flow cytometry and[99mTc]duramycin to detect the binding efficiency to apoptotic SMCs. C57/BL6 mice were administered angiotensin-II and beta-aminopropionitrile (BAPN) subcutaneously to establish an AA model, or saline for controls. Aortic specimens underwent pathological evaluation and their aortic diameters were measured after 6  weeks. Micro-SPECT/CT scanning of[99mTc]duramycin and18F-FDG PET detection were performed. SMCs treated with H2O2 showed more apoptosis compared with the control group (67.2  ± 3.8% vs. 16.1 ± 0.6%,P  <  0.01). The experimental group showed a high rate of AA formation (70%) compared with no AA formation in the control group. The average aorta diameter was higher and[99mTc]duramycin uptake at the AA site was higher in the experimental group compared with the control group. Compared with the normal aorta in the control group, AA in experiment group had more severe medial degeneration, elastic fiber reduction and fracture, and collagen degeneration. TUNEL staining verified t...
Source: Apoptosis - Category: Molecular Biology Source Type: research